mupirocin has been researched along with Abscess* in 7 studies
1 review(s) available for mupirocin and Abscess
Article | Year |
---|---|
Staphylococcus lugdunensis: An Emerging Pathogen in Skin and Soft Tissue Infections.
Topics: Abscess; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Communicable Diseases, Emerging; Female; Foot Diseases; Fusidic Acid; Humans; Insect Bites and Stings; Male; Middle Aged; Mupirocin; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus lugdunensis; Wound Infection | 2015 |
6 other study(ies) available for mupirocin and Abscess
Article | Year |
---|---|
Genomic Basis of Occurrence of Cryptic Resistance among Oxacillin- and Cefoxitin-Susceptible
The oxacillin- and cefoxitin-susceptible Topics: Abscess; Anti-Bacterial Agents; Bacterial Proteins; Cefoxitin; Female; Genomics; Humans; Lactation; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Oxacillin; Penicillin-Binding Proteins; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Decolonization of children after incision and drainage for MRSA abscess: a retrospective cohort study.
Whether decolonization following incision and drainage (I&D) for methicillin-resistant Staphylococcus aureus (MRSA) abscess decreases repeat I&D and MRSA-positive cultures in children is unknown.. Referral to the Pediatric Infectious Disease Service (PIDS) for decolonization was determined for eligible children (2003-2010), with outcomes studied over 12 months.. We identified 653 children; 54 had been seen by PIDS. In the PIDS group, no patients (0/54, 0%) had a repeat I&D. In the no PIDS group 36/599 (6%) had a repeat I&D, P = .06. Logistic regression modeling for repeat I&D showed no significant effect, odds ratio = 0.29; 95% confidence interval = 0.04-2.15; P = .23. In the PIDS group, 3 patients (3/54, 5.6%) had a repeat MRSA-positive culture. In the no PIDS group, 58/599 (9.7%) had a positive repeat culture, P = .46. Logistic regression modeling for positive culture showed no significant effect (odds ratio = 0.55; 95% confidence interval = 0.17-1.81; P = .32).. We detected no statistically significant association between decolonization and repeat I&D or MRSA-positive culture. Topics: Abscess; Administration, Intranasal; Anti-Bacterial Agents; Baths; Child; Child, Preschool; Cohort Studies; Disinfectants; Drainage; Female; Humans; Longitudinal Studies; Male; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Retrospective Studies; Risk Factors; Sodium Hypochlorite; Staphylococcal Infections; Treatment Outcome | 2015 |
[Bacterial lip abscess in an immunocompetent patient].
Lip abscesses are a potentially serious condition rarely reported in the medical literature. This disease requires prompt diagnosis and treatment with hospitalization, intravenous antibiotics, and urgent surgical drainage. Clinical knowledge of this condition is essential to guide the differential diagnosis and correctly adapt the etiological treatment. The presence of necrotic and cavitated lesions requires ruling out immunosupression or methicillin-resistant agent. We report a necrotic and cavitated bacterial lip abscess caused by methicillin-sensitive Staphylococcus aureus in an immunocompetent male. Topics: Abscess; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cheilitis; Cloxacillin; Combined Modality Therapy; Drainage; Humans; Immunocompetence; Male; Mupirocin; Staphylococcal Skin Infections; Staphylococcus aureus | 2013 |
Community-acquired methicillin-resistant staphylococcus aureus skin infection.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Combined Modality Therapy; Community-Acquired Infections; Doxycycline; Drainage; Drug Therapy, Combination; Female; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Staphylococcal Skin Infections | 2011 |
Stamping out Staphylococcus.
Topics: Abscess; Administration, Intranasal; Adult; Anti-Bacterial Agents; Down Syndrome; Humans; Male; Methicillin Resistance; Mupirocin; Staphylococcal Skin Infections; Staphylococcus aureus | 2004 |
Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens.
Potent nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase have been derived from a file compound high throughput screening hit. Optimized compounds show excellent antibacterial activity against staphylococcal and enterococcal pathogens, including strains resistant to clinical antibiotics. Compound 11 demonstrated in vivo efficacy in an S. aureus rat abscess infection model. Topics: Abscess; Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Enzyme Inhibitors; Methionine-tRNA Ligase; Quinolones; Rats; Rats, Sprague-Dawley; Staphylococcus; Staphylococcus aureus; Structure-Activity Relationship | 2002 |